Status and phase
Conditions
Treatments
About
To assess the single- and multiple-dose pharmacokinetic (PK), safety and tolerability of AVP-786 in healthy volunteers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
48 participants in 5 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal